Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03UXT
|
|||
| Former ID |
DIB002558
|
|||
| Drug Name |
Recombinant house dust mite allergy desensitization injection
|
|||
| Synonyms |
Alutard SQ (house dust mite); Maxy-320; Recombinant house dust mite allergy desensitization injection, ALK-Abello; Recombinant house dust mite allergy desensitization injection, ALK-Abello/ Torii; Allergy therapeutic (Maxy-320), Maxygen/ALK-Abello; Recombinant house dust mite allergen (sc, rhinitis/asthma prevention), ALK-Abello
Click to Show/Hide
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Terminated | [1] | |
| Company |
Maxygen Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015369) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.